X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3931) 3931
Book Review (308) 308
Publication (151) 151
Newsletter (73) 73
Book Chapter (9) 9
Magazine Article (7) 7
Conference Proceeding (5) 5
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3630) 3630
humans (3094) 3094
daunorubicin - administration & dosage (2350) 2350
male (1958) 1958
female (1872) 1872
antineoplastic combined chemotherapy protocols - therapeutic use (1533) 1533
cytarabine - administration & dosage (1503) 1503
adult (1357) 1357
middle aged (1311) 1311
oncology (1030) 1030
daunorubicin (996) 996
adolescent (993) 993
leukemia, myeloid, acute - drug therapy (907) 907
aged (888) 888
hematology (877) 877
animals (866) 866
remission induction (791) 791
vincristine - administration & dosage (662) 662
child (657) 657
chemotherapy (643) 643
daunorubicin - therapeutic use (567) 567
cancer (508) 508
treatment outcome (495) 495
child, preschool (480) 480
daunorubicin - adverse effects (472) 472
antineoplastic combined chemotherapy protocols - adverse effects (454) 454
mice (434) 434
prednisone - administration & dosage (409) 409
acute disease (401) 401
prognosis (389) 389
cyclophosphamide - administration & dosage (371) 371
pharmacology & pharmacy (370) 370
doxorubicin (367) 367
daunorubicin - pharmacology (363) 363
methotrexate - administration & dosage (362) 362
abridged index medicus (361) 361
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (361) 361
antineoplastic combined chemotherapy protocols - administration & dosage (358) 358
antibiotics, antineoplastic - administration & dosage (348) 348
time factors (347) 347
daunorubicin - analogs & derivatives (344) 344
drug administration schedule (342) 342
doxorubicin - administration & dosage (337) 337
anthracyclines (336) 336
asparaginase - administration & dosage (335) 335
thioguanine - administration & dosage (329) 329
etoposide - administration & dosage (328) 328
leukemia (321) 321
mercaptopurine - administration & dosage (312) 312
acute myelogenous leukemia (310) 310
infant (310) 310
dose-response relationship, drug (293) 293
disease-free survival (286) 286
therapy (286) 286
antineoplastic agents - administration & dosage (284) 284
leukemia, myeloid - drug therapy (281) 281
drug therapy, combination (277) 277
leukemia, myeloid, acute - mortality (276) 276
prednisolone - administration & dosage (275) 275
acute myeloid leukemia (274) 274
combined modality therapy (271) 271
rats (270) 270
acute myeloid-leukemia (262) 262
survival rate (261) 261
cytarabine - therapeutic use (245) 245
cytarabine - adverse effects (233) 233
cytarabine (229) 229
leukemia - drug therapy (229) 229
follow-up studies (227) 227
survival analysis (216) 216
mitoxantrone - administration & dosage (214) 214
idarubicin - administration & dosage (211) 211
liposomes (201) 201
recurrence (201) 201
aged, 80 and over (197) 197
retrospective studies (188) 188
idarubicin (184) 184
daunorubicin - toxicity (183) 183
daunorubicin - pharmacokinetics (181) 181
antineoplastic agents - therapeutic use (179) 179
research (178) 178
pediatrics (173) 173
leukemia, myeloid, acute - pathology (169) 169
clinical trials as topic (165) 165
aml (160) 160
leukemia, lymphoid - drug therapy (160) 160
children (159) 159
bone marrow transplantation (158) 158
young adult (158) 158
age factors (157) 157
cell line, tumor (157) 157
apoptosis (156) 156
daunorubicin - metabolism (155) 155
cells (153) 153
cytosine-arabinoside (149) 149
adriamycin (148) 148
antibiotics, antineoplastic - adverse effects (146) 146
drug resistance (145) 145
prospective studies (144) 144
medicine & public health (143) 143
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3473) 3473
Japanese (169) 169
Russian (114) 114
German (69) 69
French (47) 47
Polish (40) 40
Spanish (35) 35
Chinese (33) 33
Italian (15) 15
Czech (7) 7
Danish (4) 4
Bulgarian (2) 2
Dutch (2) 2
Hebrew (2) 2
Hungarian (2) 2
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 23, pp. 3660 - 3668
Retrospective analysis indicates that pediatric‐based therapy for acute lymphoblastic leukemia is superior to adult‐type therapy. This single institution... 
augmented Berlin‐Frankfurt‐Münster | pediatric‐based therapy | Philadelphia chromosome‐negative ALL | acute lymphoblastic leukemia | pediatric‐based regimens | Augmented Berlin-Frankfurt-Munster | Pediatric-based regimens | Acute lymphoblastic leukemia | Pediatric-based therapy | Philadelphia chromosome-negative ALL | ASPARAGINASE | pediatric-based therapy | pediatric-based regimens | PROGNOSTIC-FACTORS | PROTOCOLS | ACUTE LYMPHOCYTIC-LEUKEMIA | augmented Berlin-Frankfurt-Munster | RISK | INDUCTION | CANCER GROUP | CHILDHOOD | CHILDRENS ONCOLOGY GROUP | ONCOLOGY | MINIMAL RESIDUAL DISEASE | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Induction Chemotherapy | Male | Consolidation Chemotherapy | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Adult | Female | Maintenance Chemotherapy | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 234 - 242
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1235 - 1248
Journal Article
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 06/2012, Volume 81, Issue 2, pp. 248 - 256
Schematic illustration of drug-loaded folic acid targeted nanoparticles of mixed lipid-shell and PLGA core (FLPNPs). A functional drug carrier comprised of... 
Drug delivery | PLGA | Nanoparticle | Paclitaxel | GYNECOLOGIC-ONCOLOGY-GROUP | BIODEGRADABLE MICROSPHERES | DRUG-DELIVERY | CONTROLLED-RELEASE | PHASE-II | LIPOSOMAL DAUNORUBICIN | CANCER | RECURRENT | ENDOTHELIAL-CELLS | METASTATIC NASOPHARYNGEAL CARCINOMA | PHARMACOLOGY & PHARMACY | Polymers - administration & dosage | Nanoparticles - chemistry | Humans | Drug Carriers - administration & dosage | Polyethylene Glycols - chemistry | Drug Carriers - chemistry | Tissue Distribution | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Lipids - chemistry | Female | Paclitaxel - administration & dosage | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Lactic Acid - chemistry | Drug Compounding - methods | Chitosan - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Lipids - administration & dosage | Mice, SCID | Chemistry, Pharmaceutical | Polyethylene Glycols - administration & dosage | Particle Size | Animals | Chitosan - chemistry | Polyglycolic Acid - chemistry | Cell Line, Tumor | Folic Acid - metabolism | Polymers - chemistry | Mice | Nanoparticles - administration & dosage | HeLa Cells | Drug Delivery Systems - methods | Drugs | Phosphates | Drug delivery systems | Leukemia | Liquid chromatography | Permeability | Chromatography | Folic acid | Vehicles | Nanoparticles | Lysine | Fluorescein | Dimethyl sulfoxide | Lymphomas | Index Medicus
Journal Article
Pediatric Blood and Cancer, ISSN 1545-5009, 03/2007, Volume 48, Issue 3, pp. 254 - 261
Background. Adolescents with acute lymphoblastic leukaemia (ALL) have languished in the shadow of success of the outcome of therapy in childhood ALL. Their... 
Treatment outcome | Acute lymphoblastic leukemia | Survival | Adolescent | Young adult | YOUNG-ADULTS | MAINTENANCE CHEMOTHERAPY | RANDOMIZED-TRIALS | PROTOCOLS | survival | young adult | INDUCTION | treatment outcome | CHILDHOOD | CONSOLIDATION | THERAPY | ONCOLOGY | acute lymphoblastic leukemia | TERM FOLLOW-UP | adolescent | PEDIATRICS | CHILDRENS CANCER GROUP | HEMATOLOGY | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Prognosis | Age Factors | Humans | Male | Transplantation, Autologous | Transplantation, Homologous | Patient Selection | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Bone Marrow Transplantation | Vincristine - administration & dosage | Female | Daunorubicin - administration & dosage | Randomized Controlled Trials as Topic - statistics & numerical data | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cranial Irradiation | Remission Induction | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Methotrexate - administration & dosage | Research Design | Index Medicus
Journal Article
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 2017, Volume 39, Issue 2, pp. 81 - 89
Purpose: This study was conducted as the first clinical trial by Japan Association of Childhood Leukemia Study to improve the outcome of B-cell acute... 
clinical trial | childhood | acute lymphoblastic leukemia | STANDARD-RISK | DOXORUBICIN | CARDIOTOXICITY | CANCER | CHILDRENS ONCOLOGY GROUP | THERAPY | ONCOLOGY | ANTHRACYCLINE | CONSECUTIVE TRIALS | PEDIATRICS | BFM STUDY-GROUP | CRANIAL IRRADIATION | HEMATOLOGY | Japan - epidemiology | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Risk | Consolidation Chemotherapy | Hydrocortisone - administration & dosage | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Doxorubicin - analogs & derivatives | Vincristine - administration & dosage | Female | Maintenance Chemotherapy | Child | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Survival Rate | Treatment Outcome | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy | Cranial Irradiation | Remission Induction | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Asparaginase - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Doxorubicin - adverse effects | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 21, pp. 3239 - 3246
Journal Article
Blood, ISSN 0006-4971, 09/2001, Volume 98, Issue 5, pp. 1312 - 1320
Acute myeloid leukemia (AML) in older adults carries a poor prognosis, and the optimum treatment remains to be determined. In younger patients, treatment... 
P53 MUTATIONS | THERAPY | SOUTHWEST-ONCOLOGY-GROUP | BONE-MARROW-TRANSPLANTATION | MICROSATELLITE INSTABILITY | MYELOGENOUS LEUKEMIA | HEMATOLOGY | ELDERLY-PATIENTS | ACUTE MYELOBLASTIC-LEUKEMIA | ACUTE PROMYELOCYTIC LEUKEMIA | CLINICAL-SIGNIFICANCE | Recombinant Proteins - therapeutic use | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Age Factors | Follow-Up Studies | Humans | Leukemia, Myeloid - genetics | Middle Aged | Male | Life Tables | Leukemia, Myeloid - classification | Karyotyping | Vincristine - administration & dosage | Adult | Female | Leukemia, Myeloid - mortality | Daunorubicin - administration & dosage | Lenograstim | Prednisone - administration & dosage | Drug Administration Schedule | Interferon-alpha - therapeutic use | Etoposide - administration & dosage | Treatment Outcome | Granulocyte Colony-Stimulating Factor - therapeutic use | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Leukemia, Myeloid - drug therapy | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chromosome Aberrations | Survival Analysis | Aged | United Kingdom - epidemiology | Immunologic Factors - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 906 - 915
Journal Article